Insider · CIK 0001723629

LEE ANN L.

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001723629

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-23	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+375K sh	—	—	375,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−181K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+181K sh	—	—	180,995
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−181K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+181K sh	—	—	180,995
2025-05-21	PRMEPrime Medicine, Inc.P Purchase	Chief Technical Officer	PPurchase	+100K sh	$1.13	+$113K	100,000
2025-05-08	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+80.4K sh	—	—	241,248
2025-02-27	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+275K sh	—	—	275,000
2024-05-17	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+80.4K sh	—	—	160,832
2024-02-21	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+181K sh	—	—	180,995
2023-03-31	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Chief Technical Officer	AAward	+181K sh	—	—	180,995
2018-03-05	Juno Therapeutics, Inc.D Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−35K sh	—	—	75,788
2018-03-05	Juno Therapeutics, Inc.D Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−40.8K sh	—	—	35,000
2018-03-05	Juno Therapeutics, Inc.D Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−35K sh	—	—	0
2018-03-05	Juno Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−153K sh	—	—	0
2018-01-31	Juno Therapeutics, Inc.A Award	EVP, Technical Operations	AAward	+40.8K sh	—	—	110,792
2017-11-25	Juno Therapeutics, Inc.A Award	EVP, Technical Operations	AAward	+35K sh	—	—	35,004
2017-11-25	Juno Therapeutics, Inc.A Award	EVP, Technical Operations	AAward	+35K sh	—	—	70,004
2017-11-25	Juno Therapeutics, Inc.Stock Opton (Right to Buy)A Award	EVP, Technical Operations	AAward	+153K sh	—	—	152,900

Recent filings

Accepted (ET)
Feb 244
LEE ANN L.0001628280-26-011208
SEC(opens sec.gov)
Aug 54
LEE ANN L.0001894562-25-000051
SEC(opens sec.gov)
May 224
LEE ANN L.0001894562-25-000028
SEC(opens sec.gov)
May 124
LEE ANN L.0001894562-25-000018
SEC(opens sec.gov)
Mar 34
LEE ANN L.0001894562-25-000006
SEC(opens sec.gov)
May 214
LEE ANN L.0001894562-24-000022
SEC(opens sec.gov)
Feb 234
LEE ANN L.0001894562-24-000012
SEC(opens sec.gov)
Apr 44
LEE ANN L.0001894562-23-000002
SEC(opens sec.gov)
Mar 74
LEE ANN L.0001209191-18-017820
SEC(opens sec.gov)
Feb 24
LEE ANN L.0001209191-18-007218
SEC(opens sec.gov)
Nov 284
LEE ANN L.0001209191-17-062760
SEC(opens sec.gov)

Companies

Address

C/O PRIME MEDICINE, INC. 60 FIRST STREET

CAMBRIDGE, MA, 02141